Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds GT Biopharma Q3 EPS $(0.22) Down From $(0.17) YoY

GT Biopharma Q3 EPS $(0.22) Down From $(0.17) YoY

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.22) per share. This is a 29.41 percent decrease over losses of $(0.17) per share from the same period last year.

byMichael Horton

October 31, 2022

1 minute read

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.22) per share. This is a 29.41 percent decrease over losses of $(0.17) per share from the same period last year.

In Canada And In Jamaica You Can Produce Psychedelics — With Contrasting Legal Differences

By Lara Goldstein

January 11, 5:50 PM

Red Light Holland Moves Full Speed Towards Canadian Controlled Drugs and Substances Dealer's License

NUGL

Evercore ISI Group Downgrades F5 to In-Line

By Benzinga Newsdesk

October 11, 3:53 PM

Evercore ISI Group analyst Amit Daryanani downgrades F5 (NASDAQ:FFIV) from Outperform to In-Line.

FFIV

Apple’s $3 Trillion Crown Slips As Disappointing Sales Take Toll

By Bibhu Pattnaik

August 5, 11:51 AM

Apple Inc's (NASDAQ: AAPL) market value has dipped below the once-historic milestone of $3 trillion, triggered by

AAPL

Anthony Scaramucci Says Worst Of Bear Market Is Behind Us: ‘I Wouldn’t Sell Your Bitcoin, You Made It Through Winter’

By Mehab Qureshi

September 21, 11:29 PM

SkyBridge Capital founder Anthony Scaramucci on Wednesday expressed his continued optimism for Bitcoin (CRYPTO: BTC), even though it currently trades well below its all-time highs.

BTC

GT Biopharma Q3 EPS $(0.22) Down From $(0.17) YoY

Related Posts

In Canada And In Jamaica You Can Produce Psychedelics — With Contrasting Legal Differences

Evercore ISI Group Downgrades F5 to In-Line

Apple’s $3 Trillion Crown Slips As Disappointing Sales Take Toll

Anthony Scaramucci Says Worst Of Bear Market Is Behind Us: ‘I Wouldn’t Sell Your Bitcoin, You Made It Through Winter’